Αποτελέσματα Αναζήτησης
11 Μαρ 2022 · Drugs that target the endocannabinoid system are of interest as pharmacological options to combat cancer and to improve the life quality of cancer patients.
- Full Size Image
We would like to show you a description here but the site...
- Metrics
We would like to show you a description here but the site...
- Full Size Image
We will discuss the potential use of cannabinoids for treatment of cancer, focusing on primary outcome/care—tumor shrinkage and eradication, as well as secondary outcome/palliative care—improvement of life quality, including pain, appetite, sleep, and many more factors.
13 Μαρ 2024 · Cannabis and/or cannabinoid access and use by adults with cancer has outpaced the science supporting their clinical use. This guideline provides strategies for open, nonjudgmental communication between clinicians and adults with cancer about the use of cannabis and/or cannabinoids.
13 Μαΐ 2022 · Claims that there is solid “proof” that cannabis or cannabinoids can cure cancer are highly misleading. Unfortunately, there are many unreliable sources of information about cannabis, particularly online. This post contains up-to-date, evidence-based information on cannabis and cancer.
Cannabinoids, including Δ9-THC, CBD, and CBG, exhibit significant anticancer activities such as apoptosis induction, autophagy stimulation, cell cycle arrest, anti-proliferation, anti-angiogenesis, and metastasis inhibition. Clinical trials have demonstrated cannabinoids’ efficacy in tumor regression and health improvement in palliative care.
Nearly 40% of patients with cancer using cannabis believe it will treat their cancer with numerous anecdotal reports shared online through social media platforms. Case reports have been published in peer-reviewed journals, but often lack key clinical information to validate anticancer claims.
13 Μαρ 2024 · Adults with cancer using cannabis or cannabinoids should understand that the clinical evidence to support their use as cancer-directed therapy in humans is lacking.
